Drug
Nicotine Polacrilex Gum
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Macular Degeneration | 567 | 168.9 | 185.8 | signal |
| 2 | Oral Discomfort | 329 | 81.9 | 86.4 | signal |
| 3 | Intentional Drug Misuse | 333 | 53.9 | 56.9 | signal |
| 4 | Paraesthesia Oral | 165 | 39.3 | 40.3 | signal |
| 5 | Vaginal Discharge | 82 | 27.8 | 28.2 | signal |
| 6 | Oral Candidiasis | 84 | 22.0 | 22.3 | signal |
| 7 | Drug Administration Error | 199 | 21.8 | 22.4 | signal |
| 8 | Expired Product Administered | 209 | 21.4 | 22.1 | signal |
| 9 | Incorrect Route Of Product Administration | 94 | 19.0 | 19.3 | signal |
| 10 | Dental Caries | 58 | 17.8 | 18.0 | signal |
| 11 | Throat Irritation | 234 | 17.8 | 18.4 | signal |
| 12 | Procedural Pain | 125 | 15.3 | 15.6 | signal |
| 13 | Product Taste Abnormal | 49 | 12.4 | 12.4 | signal |
| 14 | Drug Effect Less Than Expected | 48 | 11.5 | 11.6 | signal |
| 15 | Frequent Bowel Movements | 87 | 11.0 | 11.1 | signal |
| 16 | Dyspepsia | 314 | 10.9 | 11.4 | signal |
| 17 | Oral Pain | 71 | 10.7 | 10.8 | signal |
| 18 | Salivary Hypersecretion | 30 | 10.2 | 10.2 | signal |
| 19 | Therapeutic Product Effect Incomplete | 175 | 8.4 | 8.6 | signal |
| 20 | Glossodynia | 52 | 7.9 | 7.9 | signal |
| 21 | Retching | 49 | 7.8 | 7.9 | signal |
| 22 | Stomatitis | 139 | 7.8 | 7.9 | signal |
| 23 | Colitis | 83 | 7.5 | 7.6 | signal |
| 24 | Wrong Technique In Product Usage Process | 419 | 7.0 | 7.5 | signal |
| 25 | Rectal Haemorrhage | 87 | 6.8 | 6.9 | signal |
| 26 | Pharyngeal Oedema | 31 | 6.7 | 6.8 | signal |
| 27 | Infusion Related Reaction | 125 | 6.4 | 6.5 | signal |
| 28 | Colitis Ulcerative | 84 | 6.4 | 6.5 | signal |
| 29 | Pharyngeal Swelling | 18 | 6.4 | 6.4 | signal |
| 30 | Throat Tightness | 50 | 6.3 | 6.3 | signal |
| 31 | Tooth Fracture | 20 | 6.1 | 6.2 | signal |
| 32 | Incorrect Drug Administration Duration | 49 | 5.8 | 5.9 | signal |
| 33 | Toothache | 31 | 5.8 | 5.8 | signal |
| 34 | Haematochezia | 85 | 5.2 | 5.3 | signal |
| 35 | Incorrect Route Of Drug Administration | 55 | 5.1 | 5.2 | signal |
| 36 | Dysgeusia | 107 | 4.8 | 4.9 | signal |
| 37 | Flatulence | 65 | 3.9 | 3.9 | signal |
| 38 | Hypoaesthesia Oral | 17 | 3.8 | 3.8 | signal |
| 39 | Oropharyngeal Pain | 104 | 3.8 | 3.8 | signal |
| 40 | Dry Throat | 11 | 3.7 | 3.7 | signal |
| 41 | Drug Ineffective | 1,401 | 3.6 | 4.4 | signal |
| 42 | Abdominal Discomfort | 168 | 3.4 | 3.5 | signal |
| 43 | Mouth Ulceration | 21 | 3.4 | 3.4 | signal |
| 44 | Eructation | 17 | 3.0 | 3.0 | signal |
| 45 | Feeling Jittery | 17 | 3.0 | 3.0 | signal |
| 46 | Nausea | 701 | 3.0 | 3.3 | signal |
| 47 | Gingival Bleeding | 12 | 3.0 | 3.0 | signal |
| 48 | Euphoric Mood | 9 | 3.0 | 3.0 | signal |
| 49 | Pain In Jaw | 24 | 2.9 | 2.9 | signal |
| 50 | Product Use Complaint | 13 | 2.8 | 2.8 | signal |
| 51 | Product Quality Issue | 109 | 2.7 | 2.8 | signal |
| 52 | Therapeutic Product Effect Decreased | 35 | 2.7 | 2.7 | signal |
| 53 | Accidental Exposure To Product | 75 | 2.5 | 2.6 | signal |
| 54 | Tooth Disorder | 16 | 2.4 | 2.4 | signal |
| 55 | Swollen Tongue | 22 | 2.4 | 2.4 | signal |
| 56 | Lip Swelling | 23 | 2.3 | 2.3 | signal |
| 57 | Underdose | 50 | 2.3 | 2.3 | signal |
| 58 | Incorrect Dose Administered | 150 | 2.3 | 2.3 | signal |
| 59 | Malaise | 288 | 2.2 | 2.3 | signal |
| 60 | Skin Laceration | 7 | 2.2 | 2.2 | no signal |
| 61 | Nightmare | 22 | 2.1 | 2.1 | signal |
| 62 | Dry Mouth | 49 | 2.0 | 2.1 | signal |
| 63 | Product Physical Issue | 12 | 2.0 | 2.0 | signal |
| 64 | Blood Potassium Increased | 9 | 1.9 | 1.9 | no signal |
| 65 | Pruritus Generalised | 12 | 1.8 | 1.9 | no signal |
| 66 | Product Packaging Issue | 5 | 1.8 | 1.8 | no signal |
| 67 | Drug Withdrawal Syndrome Neonatal | 8 | 1.8 | 1.8 | no signal |
| 68 | Nervousness | 28 | 1.8 | 1.8 | no signal |
| 69 | Laceration | 5 | 1.8 | 1.8 | no signal |
| 70 | Autoimmune Disorder | 5 | 1.8 | 1.8 | no signal |
| 71 | Erythema | 105 | 1.7 | 1.7 | no signal |
| 72 | Therapeutic Response Unexpected | 23 | 1.7 | 1.7 | no signal |
| 73 | Abdominal Pain Upper | 103 | 1.7 | 1.7 | no signal |
| 74 | Palpitations | 58 | 1.7 | 1.7 | no signal |
| 75 | Heart Rate Increased | 47 | 1.6 | 1.6 | no signal |
| 76 | Burning Sensation | 33 | 1.6 | 1.6 | no signal |
| 77 | Blood Glucose Increased | 88 | 1.6 | 1.6 | no signal |
| 78 | Choking | 9 | 1.6 | 1.6 | no signal |
| 79 | Drug Ineffective For Unapproved Indication | 25 | 1.5 | 1.5 | no signal |
| 80 | Brain Neoplasm | 4 | 1.5 | 1.5 | no signal |
| 81 | Application Site Rash | 6 | 1.5 | 1.5 | no signal |
| 82 | Dependence | 24 | 1.5 | 1.5 | no signal |
| 83 | Aphonia | 6 | 1.5 | 1.5 | no signal |
| 84 | Tooth Extraction | 5 | 1.4 | 1.4 | no signal |
| 85 | Product Complaint | 10 | 1.4 | 1.4 | no signal |
| 86 | Abnormal Dreams | 11 | 1.3 | 1.3 | no signal |
| 87 | Ageusia | 9 | 1.2 | 1.2 | no signal |
| 88 | Tooth Loss | 7 | 1.1 | 1.1 | no signal |
| 89 | Withdrawal Syndrome | 14 | 1.1 | 1.1 | no signal |
| 90 | Overdose | 71 | 1.1 | 1.1 | no signal |
| 91 | Respiratory Depression | 4 | 1.1 | 1.1 | no signal |
| 92 | Lymphoma | 5 | 1.1 | 1.1 | no signal |
| 93 | Increased Appetite | 6 | 1.1 | 1.1 | no signal |
| 94 | Drug Effective For Unapproved Indication | 9 | 1.0 | 1.0 | no signal |
| 95 | Adverse Reaction | 4 | 1.0 | 1.0 | no signal |
| 96 | Irritability | 18 | 1.0 | 1.0 | no signal |
| 97 | Poor Quality Product Administered | 3 | 1.0 | 1.0 | no signal |
| 98 | Local Swelling | 5 | 1.0 | 1.0 | no signal |
| 99 | Breast Pain | 3 | 1.0 | 1.0 | no signal |
| 100 | Drug Effect Decreased | 15 | 0.9 | 0.9 | no signal |
| 101 | Suicidal Ideation | 25 | 0.9 | 0.9 | no signal |
| 102 | Application Site Pruritus | 6 | 0.9 | 0.9 | no signal |
| 103 | Bone Loss | 4 | 0.9 | 0.9 | no signal |
| 104 | Mania | 4 | 0.8 | 0.8 | no signal |
| 105 | Poisoning | 3 | 0.8 | 0.8 | no signal |
| 106 | Tuberculosis | 3 | 0.8 | 0.8 | no signal |
| 107 | Glycosylated Haemoglobin Increased | 5 | 0.7 | 0.7 | no signal |
| 108 | Device Failure | 3 | 0.7 | 0.7 | no signal |
| 109 | Inappropriate Schedule Of Drug Administration | 14 | 0.7 | 0.7 | no signal |
| 110 | Application Site Erythema | 5 | 0.6 | 0.6 | no signal |
| 111 | Application Site Pain | 4 | 0.6 | 0.6 | no signal |
| 112 | No Adverse Event | 32 | 0.6 | 0.6 | no signal |
| 113 | Drug Dependence | 27 | 0.6 | 0.6 | no signal |
| 114 | Product Adhesion Issue | 5 | 0.5 | 0.5 | no signal |
| 115 | Drug Withdrawal Syndrome | 9 | 0.3 | 0.3 | no signal |